No Access
Commentary and Analysis
https://doi.org/10.1142/S021903030900038XCited by:0 (Source: Crossref)
Abstract
Facing ITC Investigation? What Chinese Biotechnology Companies Should Know About Patent Litigation in the United States International Trade Commission.
Keywords: